CMS RBCS · Imaging · Nuclear

Myocardial Perfusion Scan codes

32 CPT®/HCPCS codes, ranked by est. all-Medicare services — scaled from national Medicare Part B fee-for-service volume. Open any code for the full market view — ranked physician groups, geography, and 12-year trend.

CY2024 · National scale is an all-Medicare estimate · est. — scaled estimate — assumes MA utilization mirrors FFS; not an observation; the observed fee-for-service figure is shown adjacent. Part B · national figures

HCPCS · Nuclear imaging A9500 Technetium tc-99m sestamibi, diagnostic, per study dose CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 1.13M services · est. ▼ 8.9% YoY · 313,627 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 546,847 observed fee-for-service services

See the national market for A9500 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 772,662 services · est. ▼ 2.4% YoY · 227,297 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 378,763 observed fee-for-service services

See the national market for A9502 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 683,741 services · est. ▲ 22.9% YoY · 205,957 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 336,870 observed fee-for-service services

See the national market for A9555 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 43,665 services · est. ▼ 3.3% YoY · 20,739 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 21,471 observed fee-for-service services

See the national market for A9503 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 8,150 services · est. ▲ 6.8% YoY · 4,131 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 4,152 observed fee-for-service services

See the national market for A9541 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 6,586 services · est. ▲ 5.7% YoY · 3,219 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 3,223 observed fee-for-service services

See the national market for A9537 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9562 Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 2,857 services · est. ▲ 12.1% YoY · 1,431 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 1,470 observed fee-for-service services

See the national market for A9562 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9561 Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 2,687 services · est. ▼ 21.0% YoY · 1,330 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 1,398 observed fee-for-service services

See the national market for A9561 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9538 Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 2,261 services · est. ▼ 10.8% YoY · 1,131 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 1,135 observed fee-for-service services

See the national market for A9538 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9560 Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 1,883 services · est. ▼ 2.9% YoY · 819 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 893 observed fee-for-service services

See the national market for A9560 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9512 Technetium tc-99m pertechnetate, diagnostic, per millicurie CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 1,586 services · est. ▲ 65.9% YoY · 171 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 791 observed fee-for-service services

See the national market for A9512 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9540 Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 1,217 services · est. ▲ 1.2% YoY · 610 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 620 observed fee-for-service services

See the national market for A9540 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9520 Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2014 — first year this code appears in Part B claims

National scale 788 services · est. ▼ 11.3% YoY · 366 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 393 observed fee-for-service services

See the national market for A9520 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9567 Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 565 services · est. · 282 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 282 observed fee-for-service services

See the national market for A9567 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9539 Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 187 services · est. ▼ 10.3% YoY · 90 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 95 observed fee-for-service services

See the national market for A9539 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9521 Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 46 services · est. ▲ 25.4% YoY · 22 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 23 observed fee-for-service services

See the national market for A9521 → ranked groups · states · 12-yr trend

HCPCS · Nuclear imaging A9557 Technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 23 services · est. · 12 FFS beneficiary-episodes (CY2023, all-Medicare estimate) — 12 observed fee-for-service services

See the national market for A9557 → ranked groups · states · 12-yr trend

15 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.